marketshareAI

MaxCyte, Inc.

MXCTHealthcare
153.59GBX
-4.01%
Market Cap
163.44M
Volume
15.44k
51% of avg
P/E Ratio
-5.12
EPS (TTM)
-0.3
Beta
1.04
Day Range
152.96p - 162.00p
52 Week Range
152.96p153.59p407.84p
153.59p

Upcoming Events

June 25, 2025
Last day of trading on AIM
High Impact Event
June 26, 2025
Cancellation of admission to trading on AIM
High Impact Event
December 31, 2025
Projected cash and investments balance of $160M
High Impact Event
MXCT
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

The healthcare company reports a change in substantial shareholding by BlackRock, Inc.

MXCT
NEUTRAL

MaxCyte and Ori Biotech Collaborate to Improve Cell Therapy Manufacturing

The healthcare technology companies are collaborating to improve the efficiency and scalability of cell therapy manufacturing.

MXCT
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

The healthcare company reports a change in substantial shareholding by BlackRock, Inc.

MXCT
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

The healthcare company reports a change in substantial shareholding by BlackRock, Inc.

MXCT
NEUTRAL

MaxCyte Announces Change in Shareholding

The healthcare company has announced a change in shareholding, with BlackRock, Inc. increasing its stake in the business.

MXCT
NEUTRAL

MaxCyte Announces Director Shareholding Change

The medical device company has announced a change in director shareholding.

MXCT
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

The medical device company reports a change in substantial shareholding by BlackRock, Inc.

MXCT
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

The healthcare company reports a change in substantial shareholding by BlackRock, Inc.

MXCT
NEUTRAL

MaxCyte Announces Director Dealings

The healthcare company has announced changes to its major shareholders.

MXCT
NEUTRAL

BlackRock Increases Stake in MaxCyte

The major investor BlackRock has increased its stake in the medical device company MaxCyte.